Epilepsy GTx
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $43M
Investors
- 4
About Epilepsy GTx
Established in 2022 and based in Cambridge, UK, Epilepsy GTx operates as a late preclinical stage biotechnology research company that develops gene therapy for the treatment of seizures in patients. EpilepsyGTx develops gene therapies for focal refractory epilepsy (FRE). Their primary offering, EPY201, aims to provide seizure freedom for patients whose seizures persist despite treatment with multiple antiseizure medications.1 potassium channel, which reduces neuronal excitability and epileptic activity. The company's approach involves the targeted delivery of gene therapy to the specific area of the brain where seizures originate.
Who invested in Epilepsy GTx
4 investors across 2 rounds
See all investors in Epilepsy GTx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Epilepsy GTx
Who invested in Epilepsy GTx?
Epilepsy GTx has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epilepsy GTx raised?
Epilepsy GTx has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Epilepsy GTx last raise money?
Epilepsy GTx's most recent round on record is a Series A, in Dec 2025.
What does Epilepsy GTx do?
Established in 2022 and based in Cambridge, UK, Epilepsy GTx operates as a late preclinical stage biotechnology research company that develops gene therapy for the treatment of seizures in patients.
Where is Epilepsy GTx headquartered?
Epilepsy GTx is headquartered in Canterbury, UK.
Which VCs invest in companies like Epilepsy GTx?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Epilepsy GTx's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Epilepsy GTx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.